SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015500
Filing Date
2021-11-10
Accepted
2021-11-10 16:18:04
Documents
74
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q azyo-20210930x10q.htm   iXBRL 10-Q 1910848
2 EX-31.1 azyo-20210930xex31d1.htm EX-31.1 14660
3 EX-31.2 azyo-20210930xex31d2.htm EX-31.2 14661
4 EX-32.1 azyo-20210930xex32d1.htm EX-32.1 6769
5 EX-32.2 azyo-20210930xex32d2.htm EX-32.2 6729
  Complete submission text file 0001558370-21-015500.txt   7012680

Data Files

Seq Description Document Type Size
6 EX-101.SCH azyo-20210930.xsd EX-101.SCH 51896
7 EX-101.CAL azyo-20210930_cal.xml EX-101.CAL 43010
8 EX-101.DEF azyo-20210930_def.xml EX-101.DEF 220945
9 EX-101.LAB azyo-20210930_lab.xml EX-101.LAB 477095
10 EX-101.PRE azyo-20210930_pre.xml EX-101.PRE 370534
11 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20210930x10q_htm.xml XML 1025355
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 211396893
SIC: 2836 Biological Products, (No Diagnostic Substances)